Snowden Capital Advisors’s Bausch Health BHC Stock Holding History

Snowden Capital Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-21,762	Closed	-$181K	–	1115
2022 Q2	$181K	Buy	+21,762	New	+$304K	0.01%	1062

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Snowden Capital Advisors's BHC Position: Q3 2022 in Review

Snowden Capital Advisors sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 21,762 shares — an estimated $181K sold.

Snowden Capital Advisors first reported a position in BHC in Q2 2022 and held it in 1 quarter. The position peaked at $181K in Q2 2022. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

Snowden Capital Advisors reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
Snowden Capital Advisors sold 21,762 Bausch Health shares in Q3 2022, an estimated $181K.
Snowden Capital Advisors first reported a position in Bausch Health in Q2 2022 and held it in 1 quarter.
Snowden Capital Advisors's Bausch Health position peaked at $181K in Q2 2022.
283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Snowden Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.